Penfluridol

Jump to navigation Jump to search
Penfluridol
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC28H27ClF5NO
Molar mass523.965
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Penfluridol

Articles

Most recent articles on Penfluridol

Most cited articles on Penfluridol

Review articles on Penfluridol

Articles on Penfluridol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Penfluridol

Images of Penfluridol

Photos of Penfluridol

Podcasts & MP3s on Penfluridol

Videos on Penfluridol

Evidence Based Medicine

Cochrane Collaboration on Penfluridol

Bandolier on Penfluridol

TRIP on Penfluridol

Clinical Trials

Ongoing Trials on Penfluridol at Clinical Trials.gov

Trial results on Penfluridol

Clinical Trials on Penfluridol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Penfluridol

NICE Guidance on Penfluridol

NHS PRODIGY Guidance

FDA on Penfluridol

CDC on Penfluridol

Books

Books on Penfluridol

News

Penfluridol in the news

Be alerted to news on Penfluridol

News trends on Penfluridol

Commentary

Blogs on Penfluridol

Definitions

Definitions of Penfluridol

Patient Resources / Community

Patient resources on Penfluridol

Discussion groups on Penfluridol

Patient Handouts on Penfluridol

Directions to Hospitals Treating Penfluridol

Risk calculators and risk factors for Penfluridol

Healthcare Provider Resources

Symptoms of Penfluridol

Causes & Risk Factors for Penfluridol

Diagnostic studies for Penfluridol

Treatment of Penfluridol

Continuing Medical Education (CME)

CME Programs on Penfluridol

International

Penfluridol en Espanol

Penfluridol en Francais

Business

Penfluridol in the Marketplace

Patents on Penfluridol

Experimental / Informatics

List of terms related to Penfluridol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Penfluridol (Semap, Micefal, Longoperidol) is a highly potent, first generation diphenylbutylpiperidine antipsychotic. It was discovered at Janssen Pharmaceutica in 1968. Related to other diphenylbutylpiperidine antipsychotics, pimozide and fluspirilene, penfluridol has an extremely long elimination half-life and its effects last for many days after single oral dose. Its antipsychotic potency, in terms of dose needed to produce comparable effects, is similar to both haloperidol and pimozide. It is only slightly sedative, but often causes extrapyramidal side-effects, such as akathisia, dyskinesiae and pseudo-Parkinsonism. Penfluridol is indicated for antipsychotic treatment of chronic schizophrenia and similar psychotic disorders, it is, however, like most typical antipsychotics, being increasingly replaced by the atypical antipsychotics. Due to its extremely long lasting effects, it is often prescribed to be taken orally as tablets only once a week (q 7 days). The once-weekly doses is usually 10–60 mg.

See also

References